188 related articles for article (PubMed ID: 37051718)
1. Epigenetic escape of immunosurveillance by malignant cell precursors.
Galassi C; Galluzzi L
EMBO J; 2023 May; 42(10):e114050. PubMed ID: 37051718
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification of
Lv J; Zhou Y; Zhou N; Wang Z; Chen J; Chen H; Wang D; Zhou L; Wei K; Zhang H; Tang K; Ma J; Liu Y; Wan Y; Zhang Y; Zhang H; Huang B
Sci Transl Med; 2023 Feb; 15(681):eabq6024. PubMed ID: 36724242
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunoediting: from immunosurveillance to tumor escape.
Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD
Nat Immunol; 2002 Nov; 3(11):991-8. PubMed ID: 12407406
[TBL] [Abstract][Full Text] [Related]
4. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
[TBL] [Abstract][Full Text] [Related]
5. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
Wilczyński JR; Nowak M
Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
[TBL] [Abstract][Full Text] [Related]
6. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges.
Kunimasa K; Goto T
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963413
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of immune escape genes in cancer.
Tomasi TB; Magner WJ; Khan AN
Cancer Immunol Immunother; 2006 Oct; 55(10):1159-84. PubMed ID: 16680460
[TBL] [Abstract][Full Text] [Related]
8. MHC class I down regulation, tumour escape from immune surveillance and design of therapeutic strategies.
Bubeník J
Folia Biol (Praha); 2005; 51(1):1-2. PubMed ID: 15783085
[No Abstract] [Full Text] [Related]
9. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
10. Natural selection of tumor variants in the generation of "tumor escape" phenotypes.
Khong HT; Restifo NP
Nat Immunol; 2002 Nov; 3(11):999-1005. PubMed ID: 12407407
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell-mediated immunosurveillance of human cancer.
Malmberg KJ; Carlsten M; Björklund A; Sohlberg E; Bryceson YT; Ljunggren HG
Semin Immunol; 2017 Jun; 31():20-29. PubMed ID: 28888619
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-G and cancer immunoediting.
Urosevic M; Dummer R
Cancer Res; 2008 Feb; 68(3):627-30. PubMed ID: 18245459
[TBL] [Abstract][Full Text] [Related]
13. How do tumor stem cells actively escape from host immunosurveillance?
Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
[TBL] [Abstract][Full Text] [Related]
14. Immuno-epigenetic escape of cancer stem cells.
Galluzzi L; Kroemer G
Nat Immunol; 2022 Sep; 23(9):1300-1302. PubMed ID: 36002649
[No Abstract] [Full Text] [Related]
15. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
Vesely MD; Schreiber RD
Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
[TBL] [Abstract][Full Text] [Related]
16. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.
Matsui S; Ahlers JD; Vortmeyer AO; Terabe M; Tsukui T; Carbone DP; Liotta LA; Berzofsky JA
J Immunol; 1999 Jul; 163(1):184-93. PubMed ID: 10384115
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and tumor immunoediting: putting two and two together.
Bhatia A; Kumar Y
Expert Rev Clin Immunol; 2016 Jun; 12(6):605-7. PubMed ID: 26919116
[No Abstract] [Full Text] [Related]
18. Tumor immunoediting and immunosculpting pathways to cancer progression.
Reiman JM; Kmieciak M; Manjili MH; Knutson KL
Semin Cancer Biol; 2007 Aug; 17(4):275-87. PubMed ID: 17662614
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
[TBL] [Abstract][Full Text] [Related]
20. Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging.
Boulch M; Grandjean CL; Cazaux M; Bousso P
Trends Immunol; 2019 Nov; 40(11):1022-1034. PubMed ID: 31668676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
